Search Within

Dermatology

  1. "Adult Leukemia"
Formats
  1. Meeting Abstract (19)
  2. Journal Article (13)
  3. Research Letter (3)
  4. Book Section (1)
  5. Review (1)
Groups
  1. Adult Leukemia (37)
  2. Center for Hematologic Malignancies (37)
  3. Department of Medicine (37)
  4. Dermatology Service (37)
  5. Division of Subspecialty Medicine (37)
  6. Hematologic Malignancies, Division of (37)

More Groups

People
  1. Mario Lacouture (23)
  2. Omar Abdel-Wahab (15)
  3. Raajit Rampal (15)
  4. Eli Diamond (14)
  5. Benjamin Durham (12)
  6. Ahmet Dogan (10)

More People

Years
  1. 2025 (1)
  2. 2024 (4)
  3. 2023 (6)
  4. 2022 (5)
  5. 2021 (1)
  6. 2020 (2)

More Years

Publications
  1. Blood (12)
  2. British Journal of Haematology (3)
  3. Journal of Clinical Oncology (3)
  4. Pediatric Blood and Cancer (3)
  5. Haematologica (2)
  6. Journal of the American Academy of Dermatology (2)

More Publications

Publishers
  1. American Society of Hematology (12)
  2. John Wiley & Sons (5)
  3. American Society of Clinical Oncology (3)
  4. Wiley Periodicals, Inc (3)
  5. American Association for Cancer Research (2)
  6. Ferrata Storti Foundation (2)

More Publishers

Results (37)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Long-term outcomes with single-agent BRAF inhibitor therapy in Erdheim-Chester disease
    Research Letter

    Goyal, G.; Reiner, A. S.; Bossert, D.; Sigler, A. M.; Lacouture, M. E.; Rotemberg, V.; Francis, J. H.; Go, R. S.; Rampal, R. K.; Diamond, E. L.
    Blood (2025)

    Fulltext@MSK | Save
  • Cell-free DNA from nail clippings as source of normal control for genomic studies in hematologic malignancies
    Journal Article

    Krystel-Whittemore, M.; Petrova-Drus, K.; Ptashkin, R. N.; Ewalt, M. D.; Yao, J.; Liu, Y.; Zhu, M.; Benhamida, J.; Durham, B.; Kumar, J.; more...
    Haematologica (2024)

    Fulltext@MSK | Save
  • Dermatologic adverse events following CD19-directed CAR T-cell therapy in hematologic malignancies
    Meeting Abstract

    Storgard, R.; Reingold, R.; Parisi, R.; Dusza, S.; Noor, S.; Park, J.; Sauter, C.; Curran, K.; Perales, M.; Scordo, M.; more...
    Journal of the American Academy of Dermatology (2024)

    Fulltext@MSK | Save
  • Acute febrile neutrophilic dermatosis (sweet syndrome) in acute myeloid leukemia patients: A 28-year institutional experience
    Journal Article

    Cowen, E. A.; Barrios, D. M.; Pulitzer, M. P.; Moy, A. P.; Dusza, S. W.; De Wolf, S.; Geyer, M. B.; Markova, A.
    Acta Haematologica (2024)

    Fulltext@MSK | Save
  • Mixed histiocytic neoplasms: A multicentre series revealing diverse somatic mutations and responses to targeted therapy
    Journal Article

    Friedman, J. S.; Durham, B. H.; Reiner, A. S.; Yabe, M.; Petrova-Drus, K.; Dogan, A.; Pulitzer, M.; Busam, K. J.; Francis, J. H.; Rampal, R. K.; more...
    British Journal of Haematology (2024)

    Fulltext@MSK | Save
  • Long-term outcomes with single-agent BRAF-inhibitor therapy in Erdheim-Chester disease
    Meeting Abstract

    Goyal, G.; Reiner, A.; Bossert, D.; Sigler, A.; Buthorn, J.; Lacouture, M.; Rotemberg, V.; Francis, J. H.; Go, R. S.; Rampal, R. K.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Phase 2 trial of single-agent cobimetinib for adults with histiocytic neoplasms
    Meeting Abstract

    Diamond, E. L.; Durham, B.; Dogan, A.; Yabe, M.; Petrova-Drus, K.; Rampal, R. K.; Ulaner, G.; Lacouture, M.; Rotemberg, V.; Covey, A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Outcomes after interruption of targeted therapy in patients with histiocytic neoplasms
    Journal Article

    Reiner, A. S.; Durham, B. H.; Yabe, M.; Petrova-Drus, K.; Francis, J. H.; Rampal, R. K.; Lacouture, M. E.; Rotemberg, V.; Abdel-Wahab, O.; Panageas, K. S.; more...
    British Journal of Haematology (2023)

    Fulltext@MSK | Save
  • Dermatologic adverse events in acute lymphocytic leukemia patients treated with bispecific T-cell engager blinatumomab
    Research Letter

    Parisi, R.; Cowen, E. A.; Gu, S.; Dusza, S.; Pulitzer, M.; Geyer, M. B.; King, A. C.; Markova, A.
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • Clinical characteristics and treatment outcomes in patients with histiocytic neoplasms harboring class 3 MAP2K1 mutations, including novel treatment with the ERK inhibitor ulixertinib
    Meeting Abstract

    Diamond, E. L.; Rosenblum, M.; Yabe, M.; Petrova-Drus, K.; Francis, J. H.; Rampal, R. K.; Lacouture, M. E.; Rotemberg, V. M.; Hatzoglou, V.; Young, R.; more...
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save